NewLink Genetics cuts staff after drug trial failure

NewLink Genetics cuts staff after drug trial failure

/wp-content/uploads/2022/11/BR_web_311x311.jpeg

BPC Staff | Jun 21, 2016 | 3:54 pm |

<1 min read time

Ames-based pharmaceutical company NewLink Genetics has laid off 87 people following the failure of one its main drug candidates. NewLink primarily focuses on developing therapies to help the body's immune system fight cancer.

Des Moines Register: Ames-based pharmaceutical company NewLink Genetics has laid off 87 people following the failure of one its main drug candidates. NewLink primarily focuses on developing therapies to help the body’s immune system fight cancer.